{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:37:24Z","timestamp":1762144644136},"reference-count":80,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2009,1,6]],"date-time":"2009-01-06T00:00:00Z","timestamp":1231200000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0004124","type":"journal-article","created":{"date-parts":[[2009,1,6]],"date-time":"2009-01-06T00:30:08Z","timestamp":1231201808000},"page":"e4124","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":49,"title":["Iodine Atoms: A New Molecular Feature for the Design of Potent Transthyretin Fibrillogenesis Inhibitors"],"prefix":"10.1371","volume":"4","author":[{"given":"Teresa","family":"Mairal","sequence":"first","affiliation":[]},{"given":"Joan","family":"Nieto","sequence":"additional","affiliation":[]},{"given":"Marta","family":"Pinto","sequence":"additional","affiliation":[]},{"given":"Maria Ros\u00e1rio","family":"Almeida","sequence":"additional","affiliation":[]},{"given":"Luis","family":"Gales","sequence":"additional","affiliation":[]},{"given":"Alfredo","family":"Ballesteros","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9","family":"Barluenga","sequence":"additional","affiliation":[]},{"given":"Juan J.","family":"P\u00e9rez","sequence":"additional","affiliation":[]},{"given":"Jes\u00fas T.","family":"V\u00e1zquez","sequence":"additional","affiliation":[]},{"given":"Nuria B.","family":"Centeno","sequence":"additional","affiliation":[]},{"given":"Maria Joao","family":"Saraiva","sequence":"additional","affiliation":[]},{"given":"Ana M.","family":"Damas","sequence":"additional","affiliation":[]},{"given":"Antoni","family":"Planas","sequence":"additional","affiliation":[]},{"given":"Gemma","family":"Arsequell","sequence":"additional","affiliation":[]},{"given":"Gregorio","family":"Valencia","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2009,1,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1098\/rstb.2000.0758","article-title":"The structural basis of protein folding and its links with human disease.","volume":"356","author":"CM Dobson","year":"2001","journal-title":"Phil Trans R Soc Lond B Biol Sci"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev.biochem.75.101304.123901","article-title":"Protein misfolding, functional amyloid, and human disease.","volume":"75","author":"F Chiti","year":"2006","journal-title":"Annu Rev Biochem"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/nm1113","article-title":"Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs.","volume":"10","author":"MS Forman","year":"2004","journal-title":"Nat Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1073\/pnas.87.7.2843","article-title":"Fibril in senile systemic amyloidosis is derived from normal transthyretin.","volume":"87","author":"P Westermark","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/clc.4960210804","article-title":"A review of amyloidoses that infiltrate the heart.","volume":"21","author":"RE McCarthy","year":"1998","journal-title":"Clin Cardiol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/humu.1132","article-title":"Transthyretin mutations in hyperthyroxinemia and amyloid diseases.","volume":"17","author":"MJ Saraiva","year":"2001","journal-title":"Hum Mutat"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/mus.20821","article-title":"The molecular biology and clinical features of amyloid neuropathy.","volume":"36","author":"MD Benson","year":"2007","journal-title":"Muscle Nerve"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1210\/jcem-37-3-415","article-title":"Transport of thyroid hormones in serum and cerebrospinal fluid.","volume":"37","author":"GA Hagen","year":"1973","journal-title":"J Clin Endocrinol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1172\/JCI105889","article-title":"Retinol-binding protein: the transport protein of vitamin A in human plasma.","volume":"47","author":"M Kanai","year":"1968","journal-title":"J Clin Invest"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0022-2836(71)90218-X","article-title":"An X-ray study of the subunit structure of prealbumin.","volume":"61","author":"CC Blake","year":"1971","journal-title":"J Mol Biol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0022-2836(78)90368-6","article-title":"Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 \u00c5.","volume":"121","author":"CC Blake","year":"1978","journal-title":"J Mol Biol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"16612","DOI":"10.1021\/bi0511484","article-title":"Partitioning conformational intermediates between competing refolding and aggregation pathways: insights into transthyretin amyloid disease.","volume":"44","author":"RL Wiseman","year":"2005","journal-title":"Biochemistry"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"15525","DOI":"10.1021\/bi051608t","article-title":"The pathway by which the tetrameric protein transthyretin dissociates.","volume":"44","author":"TR Foss","year":"2005","journal-title":"Biochemistry"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"7365","DOI":"10.1021\/bi049621l","article-title":"Transthyretin aggregation under partially denaturing conditions is a downhill polymerization.","volume":"43","author":"AR Hurshman","year":"2004","journal-title":"Biochemistry"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"27207","DOI":"10.1074\/jbc.M101024200","article-title":"Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants.","volume":"276","author":"A Quintas","year":"2001","journal-title":"J Biol Chem"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jmb.2008.07.029","article-title":"Structural insight into pH-induced conformational changes within the native human transthyretin tetramer.","volume":"382","author":"SK Palaninathan","year":"2008","journal-title":"J Mol Biol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1021\/bi800636q","article-title":"Quantification of the thermodynamically linked quaternary and tertiary structural stabilities of transthyretin and its disease-associated variants: the relationship between stability and amyloidosis.","volume":"47","author":"AR Hurshman Babbes","year":"2008","journal-title":"Biochemistry"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1073\/pnas.0711908105","article-title":"An experimental survey of the transition between two-state and downhill protein folding scenarios.","volume":"105","author":"F Liu","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1074\/jbc.M708028200","article-title":"Human-murine transthyretin heterotetramers are kinetically stable and non-amyloidogenic. A lesson in the generation of transgenic models of diseases involving oligomeric proteins.","volume":"283","author":"N Reixach","year":"2008","journal-title":"J Biol Chem"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1529\/biophysj.106.085928","article-title":"Fourier transform infrared spectroscopy provides a fingerprint for the tetramer and for the aggregates of transthyretin.","volume":"91","author":"Y Cordeiro","year":"2006","journal-title":"Biophys J"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"9265","DOI":"10.1021\/bi050352o","article-title":"Kinetic stabilization of an oligomeric protein under physiological conditions demonstrated by a lack of subunit exchange: implications for transthyretin amyloidosis.","volume":"44","author":"RL Wiseman","year":"2005","journal-title":"Biochemistry"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1021\/ja042929f","article-title":"Kinetic stabilization of an oligomeric protein by a single ligand binding event.","volume":"127","author":"RL Wiseman","year":"2005","journal-title":"J Am Chem Soc"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jmb.2005.01.050","article-title":"Kinetic stabilization of the native state by protein engineering: implications for inhibition of transthyretin amyloidogenesis.","volume":"347","author":"TR Foss","year":"2005","journal-title":"J Mol Biol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/labinvest.3700059","article-title":"Native state stabilization by NSAIDs inhibits transthyretin amyloidogenesis from the most common familial disease variants.","volume":"84","author":"SR Miller","year":"2004","journal-title":"Lab Invest"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1006\/jsbi.2000.4273","article-title":"Review: TTR amyloidosis \u2013 structural features leading to protein aggregation and their implications on therapeutic strategies.","volume":"130","author":"AM Damas","year":"2000","journal-title":"J Struct Biol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"15051","DOI":"10.1073\/pnas.93.26.15051","article-title":"Inhibiting transthyretin amyloid fibril formation via protein stabilization.","volume":"93","author":"GJ Miroy","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1126\/science.1079589","article-title":"Prevention of transthyretin amyloid disease by changing protein misfolding energetics.","volume":"299","author":"P Hammarstrom","year":"2003","journal-title":"Science"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1021\/ar020073i","article-title":"Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: a focus on the transthyretin amyloidoses.","volume":"38","author":"SM Johnson","year":"2005","journal-title":"Acc Chem Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1021\/jm800435s","article-title":"Toward Optimization of the Linker Substructure Common to Transthyretin Amyloidogenesis Inhibitors Using Biochemical and Structural Studies.","volume":"51","author":"SM Johnson","year":"2008","journal-title":"J Med Chem"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1073\/pnas.0700316104","article-title":"Synthesis and evaluation of transthyretin amyloidosis inhibitors containing carborane pharmacophores.","volume":"104","author":"RL Julius","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.bbrc.2006.07.109","article-title":"Cell based screening of inhibitors of transthyretin aggregation.","volume":"348","author":"N Reixach","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"14545","DOI":"10.1073\/pnas.0501609102","article-title":"Genistein, a natural product from soy, is a potent inhibitor of transthyretin amyloidosis.","volume":"102","author":"NS Green","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"6662","DOI":"10.1021\/ja044351f","article-title":"Potent and selective structure-based dibenzofuran inhibitors of transthyretin amyloidogenesis: kinetic stabilization of the native state.","volume":"127","author":"HM Petrassi","year":"2005","journal-title":"J Am Chem Soc"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1021\/jm049274d","article-title":"Bisaryloxime ethers as potent inhibitors of transthyretin amyloid fibril formation.","volume":"48","author":"SM Johnson","year":"2005","journal-title":"J Med Chem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.bmcl.2004.12.022","article-title":"Design, synthesis, and evaluation of oxazole transthyretin amyloidogenesis inhibitors.","volume":"15","author":"H Razavi","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.chembiol.2004.10.009","article-title":"Hydroxylated polychlorinated biphenyls selectively bind transthyretin in blood and inhibit amyloidogenesis: rationalizing rodent PCB toxicity.","volume":"11","author":"HE Purkey","year":"2004","journal-title":"Chem Biol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/labinvest.3700059","article-title":"Native state stabilization by NSAIDs inhibits transthyretin amyloidogenesis from the most common familial disease variants.","volume":"84","author":"SR Miller","year":"2004","journal-title":"Lab Invest"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"13404","DOI":"10.1021\/ja030294z","article-title":"Synthesis and characterization of potent bivalent amyloidosis inhibitors that bind prior to transthyretin tetramerization.","volume":"125","author":"NS Green","year":"2003","journal-title":"J Am Chem Soc"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1021\/jm010257n","article-title":"Synthesis, structure, and activity of diclofenac analogues as transthyretin amyloid fibril formation inhibitors.","volume":"45","author":"VB Oza","year":"2002","journal-title":"J Med Chem"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/74082","article-title":"Rational design of potent human transthyretin amyloid disease inhibitors.","volume":"7","author":"T Klabunde","year":"2000","journal-title":"Nat Struct Biol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0968-0896(99)00066-8","article-title":"Synthesis and evaluation of inhibitors of transthyretin amyloid formation based on the non-steroidal antiinflammatory drug, flufenamic acid.","volume":"7","author":"PW Baures","year":"1999","journal-title":"Bioorg Med Chem"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0960-894X(98)00696-9","article-title":"Synthesis and evaluation of anthranilic acid-based transthyretin amyloid fibril inhibitors.","volume":"9","author":"VB Oza","year":"1999","journal-title":"Bioorg Med Chem Lett"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0968-0896(98)00130-8","article-title":"Discovering transthyretin amyloid fibril inhibitors by limited screening.","volume":"6","author":"PW Baures","year":"1998","journal-title":"Bioorg Med Chem"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1021\/jm0708735","article-title":"Biochemical and structural evaluation of highly selective 2-arylbenzoxazole-based transthyretin amyloidogenesis inhibitors.","volume":"51","author":"SM Johnson","year":"2008","journal-title":"J Med Chem"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1002\/anie.200351179","article-title":"Benzoxazoles as transthyretin amyloid fibril inhibitors: synthesis, evaluation, and mechanism of action.","volume":"42","author":"H Razavi","year":"2003","journal-title":"Angew Chem Int Ed"},{"key":"ref46","first-page":"119","article-title":"Multiple modes of binding of thyroid hormones and other iodothyronines to human plasma transthyretin.","author":"P De la Paz","year":"1992"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1185\/03007997809108993","article-title":"The chemistry, pharmacology and clinical pharmacology of diflunisal.","volume":"5","author":"SL Steelman","year":"1978","journal-title":"Curr Med Res Opin"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"11887","DOI":"10.1074\/jbc.M709638200","article-title":"The modulation of transthyretin tetramer stability by cysteine 10 adducts and the drug diflunisal. Direct analysis by fluorescence-detected analytical ultracentrifugation.","volume":"283","author":"JS Kingsbury","year":"2008","journal-title":"J Biol Chem"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/13506120701464396","article-title":"In vivo stabilization of mutant human transthyretin in transgenic mice.","volume":"14","author":"CE Tagoe","year":"2007","journal-title":"Amyloid"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1080\/13506120600960882","article-title":"Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis.","volume":"13","author":"Y Sekijima","year":"2006","journal-title":"Amyloid"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.neures.2006.08.014","article-title":"Diflunisal stabilizes familial amyloid polyneuropathy-associated transthyretin variant tetramers in serum against dissociation required for amyloidogenesis.","volume":"56","author":"K Tojo","year":"2006","journal-title":"Neurosci Res"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1021\/jm030347n","article-title":"Diflunisal analogues stabilize the native state of transthyretin. Potent inhibition of amyloidogenesis.","volume":"47","author":"SL Adamski-Werner","year":"2004","journal-title":"J Med Chem"},{"key":"ref53","article-title":"Boston University, Food and Drug Administration (FDA) and National Institute of Neurological Disorders and Stroke (NINDS): The effect of diflunisal on familial amyloidosis, ClinicalTrials.gov identifier: NCT00294671"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1021\/cc049849s","article-title":"Kinetic assay for high-throughput screening of <italic>in vitro<\/italic> transthyretin amyloid fibrillogenesis inhibitors.","volume":"7","author":"I Dolado","year":"2005","journal-title":"J Comb Chem"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1042\/BJ20040011","article-title":"Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative.","volume":"381","author":"MR Almeida","year":"2004","journal-title":"Biochem J"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF02820508","article-title":"Thyroxine binding to transthyretin Met 119. Comparative studies of different heterozygotic carriers and structural analysis.","volume":"6","author":"MR Almeida","year":"1997","journal-title":"Endocrine"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0009-2797(93)90081-9","article-title":"Structure-dependent, competitive interaction of hydroxy-polychlorobiphenyls -dibenzo-<italic>p<\/italic>-dioxins and -dibenzofurans with human transthyretin.","volume":"88","author":"MC Lans","year":"1993","journal-title":"Chem Biol Interact"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"16427","DOI":"10.1073\/pnas.202495199","article-title":"Sequence-dependent denaturation energetics: A major determinant in amyloid disease diversity.","volume":"25","author":"P Hammarstrom","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-4347(95)00425-4","article-title":"Drug-protein binding studies new trends in analytical and experimental methodology.","volume":"677","author":"J Oravcova","year":"1996","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"8554","DOI":"10.1016\/S0021-9258(19)40795-3","article-title":"Studies on thyroid hormone-binding proteins. II. Binding of thyroid hormones, retinol-binding protein, and fluorescent probes to prealbumin and effects of thyroxine on prealbumin subunit self association.","volume":"250","author":"SF Nilsson","year":"1975","journal-title":"J Biol Chem"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1042\/BJ20042035","article-title":"Human transthyretin in complex with iododiflunisal: structural features associated with a potent amyloid inhibitor.","volume":"388","author":"L Gales","year":"2005","journal-title":"Biochem J"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2174\/156800705774322076","article-title":"Small transthyretin (TTR) ligands as possible therapeutic agents in TTR amyloidoses. Curr.","volume":"4","author":"MR Almeida","year":"2005","journal-title":"Drug Targets CNS Neurol Disord"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"16789","DOI":"10.1073\/pnas.0407607101","article-title":"Halogen bonds in biological molecules.","volume":"101","author":"P Aufinger","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.1021\/ja00124a002","article-title":"A second generation force field for the simulation fo proteins, nucleic acids, and organic molecules.","volume":"117","author":"WD Cornell","year":"1995","journal-title":"J Am Chem Soc"},{"key":"ref65","article-title":"AMBER Version 6. University of California, San Francisco","author":"DA Case","year":"1999"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1021\/jm00145a002","article-title":"A computational procedure for determining energetic favourable binding site of biological important macromolecules.","volume":"28","author":"PJ Goodford","year":"1985","journal-title":"J Med Chem"},{"key":"ref67","article-title":"Insight II, Version 2000."},{"key":"ref68","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1039\/C39920001016","article-title":"An expeditious and general aromatic iodination procedure.","volume":"14","author":"J Barluenga","year":"1992","journal-title":"J Chem Soc Chem Commun"},{"key":"ref69","first-page":"145","article-title":"Iodonium Chemistry: More than a Simple Mimicry of Some Transition Metal Based Organic Transformations.","author":"J Barluenga","year":"1999"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1351\/pac199971081385","article-title":"Recent advances in selective organic synthesis mediated by transition metal complexes.","volume":"71","author":"J Barluenga","year":"1999","journal-title":"Pure Appl Chem"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"11453","DOI":"10.1021\/bi010673+","article-title":"Anion shielding of electrostatic repulsions in transthyretin modulates stability and amyloidosis: insight into the chaotrope unfolding dichotomy.","volume":"40","author":"P Hammarstr\u00f6m","year":"2001","journal-title":"Biochemistry"},{"key":"ref72","first-page":"50","article-title":"Crystallographic Computing 5: From Chemistry to Biology","author":"AGW Leslie","year":"1992"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1107\/S0907444994003112","article-title":"The CCP4 suite: programs for protein crystallography.","volume":"50","year":"1994","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1107\/S0907444905001617","article-title":"Likelihood-enhanced fast translation functions.","volume":"6","author":"AJ McCoy","year":"2005","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1006\/jmbi.2000.4415","article-title":"Transthyretin stability as a key factor in amyloidogenesis: X-ray analysis at atomic resolution.","volume":"306","author":"MP Sebastiao","year":"2001","journal-title":"J Mol Biol"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0959-440X(98)80152-8","article-title":"Recent developments for the efficient crystallographic refinement of macromolecular structures.","volume":"8","author":"AT Brunger","year":"1998","journal-title":"Curr Opin Struct Biol"},{"key":"ref77","article-title":"TurboFRODO in Silicon Graphics Geometry.","author":"A Roussel","year":"1991"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1107\/S0907444998007100","article-title":"Databases in protein crystallography.","volume":"54","author":"GJ Kleywegt","year":"1998","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1107\/S0907444996012255","article-title":"Refinement of macromolecular structures by the maximum-likelihood method.","volume":"53","author":"GN Murshudov","year":"1997","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ref80","first-page":"238","article-title":"PROCHECK \u2013 A program to check the stereochemical quality of protein structures.","volume":"6","author":"RA Laskowski","year":"1993","journal-title":"J Appl Crystall"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0004124","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T10:44:45Z","timestamp":1632912285000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0004124"}},"subtitle":[],"editor":[{"given":"Hilal","family":"Lashuel","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2009,1,6]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2009,1,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0004124","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,6]]}}}